SPRINT-TB Projects in the TB Drug Pipeline Report

In August 2016, several SPRINT-TB drug development projects were included in the TB Drug Pipeline report compiled by the Working Group on New TB Drugs. The Working Group on New Drugs (WGND) is one of the Stop TB Partnership's seven Working Groups — a network of experts dedicated to speeding up the development of effective, affordable new TB treatments. The WGND serves as a forum that encourages global collaboration and joint projects for new TB drug development and helps coordinate all stakeholders involved.

Explore the WGND TB drug pipeline at http://www.newtbdrugs.org .